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Background Over the past few decades, there has been a 
worldwide escalation in incidence of prostate cancer1. 
Incidence is highest in countries such as Australia, New 
Zealand, North America and Western Europe, where testing for 
Prostate Specific  Antigen (PSA) is common practice2.The five 
year survival rate in developed nations is relatively high3,4, and 
health services are struggling to cope with the increasing 
number of men who have completed treatment and require 
follow-up care. Moreover, studies demonstrate that men have a 
range of physical and psychosocial needs which currently are 
not being met5-7. New sustainable models of service delivery 
are required to ensure health systems can respond to this 
growing challenge. 
The True NTH Supported Self-Management and 
Follow Up Care Programme is an evidence based solution 
which encompasses self-management and remote monitoring 
principles. Face-to-face follow up consultations are replaced with 
patient directed, individually tailored care. The initiative is part of 
the Movember Foundation’s True NTH global programme, 
facilitated in the UK by Prostate Cancer UK. 
Programme model
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For infomation about True NTH, see: 
https://uk.movember.com/news/7593/introducing-truenth/?search-
scope=local&category_id=1 or http://prostatecanceruk.org/for-health-
professionals/our-projects/truenth
Logic model
Evaluation aims i) to compare key outcomes for men in the 
Care Programme with men who have received clinic based follow 
up care; ii) to compare costs of the Care Programme with clinic 
based follow up care at both service and patient level; iii) to 
document health care professionals’ and patients’ experiences of 
follow up care iv) to document processes which promote or inhibit 
the Care Programme’s implementation. Evaluation methods 
Outcome evaluation using a controlled cohort design with pre- and 
post-test measures. Key outcomes are general and cancer specific 
quality of life; unmet needs; fear of recurrence; anxiety and 
depression; skills for self-management; healthy behaviour change; 
satisfaction with follow up care. Embedded health economics and 
process evaluations are also being conducted. Setting Men are 
recruited from four regional cancer centres in the UK where the 
Care Programme is being implemented.
Evaluation design
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* Eligibility criteria
• Treated by radiotherapy, radical prostatectomy or primary androgen therapy
• Functionally stable and suitable for remote monitoring
• 6 weeks/3 months- 36 months post treatment
• 18 years + and English speaking
